Chondrosarcoma - 30 Studies Found
Active, not recruiting |
: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma :
: 2009-06-25 : Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months |
Recruiting |
: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma :
: 2014-02-14 : Drug: Pazopanib Treatment will continue until disease progression, development of unacceptable toxicity, |
Active, not recruiting |
: Vismodegib in Treating Patients With Advanced Chondrosarcomas :
|
Recruiting |
: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma :
|
Completed |
: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma : Sarcoma : 2003-12-10 :
|
Completed |
: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 :
: 2012-05-29 : Drug: IPI-926 IPI-926 is administered orally as a capsule formulation, as a fixed dose in mg/day. Patien |
Completed |
: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas :
|